Key facts
- Notable investors include iO life ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Kallisio
- ·The full record, as it builds
Funding rounds
No funding rounds for Kallisio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kallisio
Developer of head and neck cancer solutions designed to safeguard your patients against radiation-induced harm. The company offers 3D printed patient-specific immobilization devices that provide unparalleled protection to organs at Risk (OARs) while allowing radoncs to deliver the effective dose of radiation treatment, enhancing treatment options and ultimately the quality of life for patients
- Sector
- Healthcare
- HQ
- Baltimore, MD, United States
- Founded
- 2022
- Employees
- 15
- Website
- kallisio.com/
- Ownership
- Privately Held (backing)
Kallisio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kallisio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kallisio in its N-PORT filings yet. We sweep new filings monthly.